Huang, Alexander C. http://orcid.org/0000-0002-0099-0492
Zappasodi, Roberta http://orcid.org/0000-0002-7031-6671
Funding for this research was provided by:
Parker Institute for Cancer Immunotherapy National Institute of Health
Doris Duke Charitable Foundation
Damon Runyon Cancer Research Foundation
National Institute of Health
Article History
Received: 18 September 2021
Accepted: 18 January 2022
First Online: 3 March 2022
Competing interests
: A. C. H. is a consultant for Immunai and receives research support from Bristol Myers Squibb. R. Z. is inventor on patent applications related to work on GITR, PD-1, and CTLA-4. R. Z. is a scientific advisory board member of iTEOS Therapeutics and receives grant support from AstraZeneca and Bristol Myers Squibb.
Free to read: This content has been made available to all.